The Gross Law Firm Reminds TransMedics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 15, 2025 - TMDX

1. TMDX faces allegations of kickbacks and fraudulent practices from 2023 to 2025. 2. Investors encouraged to contact Gross Law Firm for possible class action participation. 3. The company is accused of hiding safety issues and questionable oversight. 4. Shareholders may pursue compensation for stock value inflation due to misleading statements. 5. Critical deadline for lead plaintiff appointment is April 15, 2025.

Legal

85

4m saved

Insight

Article

FAQ

Why Very Bearish?

Allegations of fraud and safety issues can severely undermine investor trust, likely leading to significant stock price drops, similar to past class action cases like Enron, where misleading practices resulted in catastrophic losses.

How important is it?

The implications of a class action lawsuit based on severe allegations can lead to substantial volatility and a longer-term decline in TMDX's stock price, affecting investor behavior significantly.

Why Short Term?

The urgency of the class action and investor anxiety can lead to immediate stock price fluctuations as shareholders react to the news, as seen with similar cases affecting other companies.

Related Companies

ENRON MGT ABUS

NEW YORK, March 10, 2025 /PRNewswire/ --

The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. (NASDAQ: TMDX).

Shareholders who purchased shares of TMDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE: https://securitiesclasslaw.com/securities/transmedics-group-inc-loss-submission-form-2/?id=134607&from=4

CLASS PERIOD:

February 28, 2023 to January 10, 2025

ALLEGATIONS:

The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

DEADLINE:

April 15, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/transmedics-group-inc-loss-submission-form-2/?id=134607&from=4

NEXT STEPS FOR SHAREHOLDERS:

Once you register as a shareholder who purchased shares of TMDX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 15, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

SOURCE The Gross Law Firm